CYP 3.85% 25.0¢ cynata therapeutics limited

Ann: June 2019 Quarterly Report, page-5

  1. 2,013 Posts.
    lightbulb Created with Sketch. 1171
    I thought it was a goodish report.

    Pfiefers thinking/analysis on the structural aspects being likely related to the old WARF agreements and sub-licensing seems to have been confirmed. Was good to get some clarity on that.

    The sentence toward the end on intellectual property seems to be missing a bit - maybe a full stop instead of the word "on"? Not that it matters much but I wonder how it would have been meant to be read.

    I should know this - but all CYP patents and IP are essentially WARF patents and IP that CYP helps pay for or does pay for - they don't have independent IP in any areas do they. Sometimes the shorthand references suggest they do - but I don't think they do.

    Everything is a license referencing back to WARF held patents?

    I think it would be good to have an updated list of patents, licenses etc as I don't think there has been a list as such since the ECO prospectus - could be wrong though.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.